盐析液-液萃取在药物制剂和生物样品中奥马他环素荧光定量新方法中的适用性

IF 0.7 4区 医学 Q4 PHARMACOLOGY & PHARMACY Current Pharmaceutical Analysis Pub Date : 2024-07-12 DOI:10.2174/0115734129322131240708103234
Eman Alzahrani, Mohamed A. Abdel-Lateef, Baher I. Salman
{"title":"盐析液-液萃取在药物制剂和生物样品中奥马他环素荧光定量新方法中的适用性","authors":"Eman Alzahrani, Mohamed A. Abdel-Lateef, Baher I. Salman","doi":"10.2174/0115734129322131240708103234","DOIUrl":null,"url":null,"abstract":"\n\nA detectable innovative fluorimetric method was used to determine OMC in\nhuman plasma matrices, pharmaceutical tablets, and vials with high recovery rates and without biological\ninterference.\n\n\n\nThe fluorimetric technique was used based on the interaction between 4-chloro7-nitrobenzofurazan\n(NBD-Cl) with a (2-ry amine group) in OMC with pH 8.0, which generates a fluorescent\ncompound measured at 530 nm (exci 470 nm) following a 10-minute heating step at 80 oC.\nThe plasma and milk samples were treated with ammonium sulfate as a salting-out procedure.\n\n\n\nOmadacycline (OMC) was successfully determined in pharmaceutical, plasma, and milk\nsamples with a linear range from 60.0 to 700.0 ng mL-1, with the lower limit of detection (LOD\n5.18 ng mL-1) and limit of quantitation (LOQ 15.72 ng mL-1).\n\n\n\nThis simple, reliable, and detectable fluorimetric method was successfully developed\nto determine omadacycline in pharmaceutical tablets, plasma samples, and milk with high recovery\nrates.\n","PeriodicalId":10889,"journal":{"name":"Current Pharmaceutical Analysis","volume":null,"pages":null},"PeriodicalIF":0.7000,"publicationDate":"2024-07-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Applicability of Salting-Out Liquid-Liquid Extraction for New Fluorimetric Quantification of Omadacycline in Pharmaceutical Formulations and\\nBiological Samples\",\"authors\":\"Eman Alzahrani, Mohamed A. Abdel-Lateef, Baher I. Salman\",\"doi\":\"10.2174/0115734129322131240708103234\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n\\nA detectable innovative fluorimetric method was used to determine OMC in\\nhuman plasma matrices, pharmaceutical tablets, and vials with high recovery rates and without biological\\ninterference.\\n\\n\\n\\nThe fluorimetric technique was used based on the interaction between 4-chloro7-nitrobenzofurazan\\n(NBD-Cl) with a (2-ry amine group) in OMC with pH 8.0, which generates a fluorescent\\ncompound measured at 530 nm (exci 470 nm) following a 10-minute heating step at 80 oC.\\nThe plasma and milk samples were treated with ammonium sulfate as a salting-out procedure.\\n\\n\\n\\nOmadacycline (OMC) was successfully determined in pharmaceutical, plasma, and milk\\nsamples with a linear range from 60.0 to 700.0 ng mL-1, with the lower limit of detection (LOD\\n5.18 ng mL-1) and limit of quantitation (LOQ 15.72 ng mL-1).\\n\\n\\n\\nThis simple, reliable, and detectable fluorimetric method was successfully developed\\nto determine omadacycline in pharmaceutical tablets, plasma samples, and milk with high recovery\\nrates.\\n\",\"PeriodicalId\":10889,\"journal\":{\"name\":\"Current Pharmaceutical Analysis\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.7000,\"publicationDate\":\"2024-07-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current Pharmaceutical Analysis\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2174/0115734129322131240708103234\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Pharmaceutical Analysis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/0115734129322131240708103234","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

采用可检测的创新荧光法测定人血浆基质、药片和药瓶中的奥马西林,回收率高且不受生物干扰。荧光法是基于 pH 值为 8.0 的奥马西林中 4-氯 7-硝基苯并呋喃(NBD-Cl)与 2-芳香胺基团的相互作用,在 80 摄氏度下加热 10 分钟后,产生的荧光化合物在 530 纳米(前 470 纳米)波长下测量。成功地测定了药物、血浆和牛奶样品中的奥马他环素(Omadacycline,OMC),线性范围为 60.0 至 700.0 ng mL-1,检测下限(LOD5.该方法简便、可靠、灵敏度高、回收率高。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Applicability of Salting-Out Liquid-Liquid Extraction for New Fluorimetric Quantification of Omadacycline in Pharmaceutical Formulations and Biological Samples
A detectable innovative fluorimetric method was used to determine OMC in human plasma matrices, pharmaceutical tablets, and vials with high recovery rates and without biological interference. The fluorimetric technique was used based on the interaction between 4-chloro7-nitrobenzofurazan (NBD-Cl) with a (2-ry amine group) in OMC with pH 8.0, which generates a fluorescent compound measured at 530 nm (exci 470 nm) following a 10-minute heating step at 80 oC. The plasma and milk samples were treated with ammonium sulfate as a salting-out procedure. Omadacycline (OMC) was successfully determined in pharmaceutical, plasma, and milk samples with a linear range from 60.0 to 700.0 ng mL-1, with the lower limit of detection (LOD 5.18 ng mL-1) and limit of quantitation (LOQ 15.72 ng mL-1). This simple, reliable, and detectable fluorimetric method was successfully developed to determine omadacycline in pharmaceutical tablets, plasma samples, and milk with high recovery rates.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
1.50
自引率
0.00%
发文量
85
审稿时长
3 months
期刊介绍: Aims & Scope Current Pharmaceutical Analysis publishes expert reviews and original research articles on all the most recent advances in pharmaceutical and biomedical analysis. All aspects of the field are represented including drug analysis, analytical methodology and instrumentation. The journal is essential to all involved in pharmaceutical, biochemical and clinical analysis.
期刊最新文献
Simultaneous Estimation of Pregabalin and Duloxetine Used to Treat Nerve Pain by Stability Indicating RP-HPLC Method Using the QBD Approach Research on Compatibility of Packaging Materials of High-Risk Cephalosporin Powder Injection and Establishment of Indicator Component Evaluation Method Universally Applicable Methods for Comprehensive Risk Assessment of Elemental Impurities in Vitamin A and D Preparations An Overview of Biotechnological Drug’s Various Techniques of Downstream Process, Guideline’s And Different Chromatographic Analysis Validation of GF-AAS Method for the Determination of Aluminium Content in Human Albumin Finished Product
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1